Cite
HARVARD Citation
Gajate Borau, P. et al. (n.d.). 823PEfficacy of therapies after progression to up-front docetaxel (D) with androgen deprivation therapy (ADT) for metastatic hormone-sensitive prostate cancer (mHSPC). Annals of oncology. p. . [Online].